KEY FEATURES
| Full Name | Versican/PG-M |
|---|---|
| Synonym | CSPG2;VCAN;ERVR;PG-M;WGN;WGN1;Chondroitin Sulfate Proteoglycan 2;Versican Proteoglycan; |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.31-20ng/mL |
| Sensitivity | 0.19ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human VCAN in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human VCAN. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human VCAN and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human VCAN, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human VCAN. You can calculate the concentration of Human VCAN in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human VCAN ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 1 | 2.36 | 7.63 | 0.96 | 2.37 | 7.22 |
| Standard deviation | 0.07 | 0.12 | 0.27 | 0.05 | 0.14 | 0.38 |
| CV(%) | 6.61 | 5.17 | 3.49 | 5.39 | 5.9 | 5.24 |
RECOVERY
The recovery of Human VCAN spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 95-105 | 100 |
| EDTA plasma (n=8) | 95-108 | 101 |
| Cell culture media (n=8) | 94-108 | 102 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human VCAN in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with VS ELISA Kits
| DCN ELISA Kit | publications with VS and DCN |
| BGN ELISA Kit | publications with VS and BGN |
| SDC4 ELISA Kit | publications with VS and SDC4 |
| SDC1 ELISA Kit | publications with VS and SDC1 |
| SDC2 ELISA Kit | publications with VS and SDC2 |
| SDC3 ELISA Kit | publications with VS and SDC3 |
| GPC1 ELISA Kit | publications with VS and GPC1 |
Pathways associated with VS ELISA Kit
| A Tetrasaccharide Linker Sequence Is Required For GAG Synthesis Pathway | A Tetrasaccharide Linker Sequence Is Required For GAG Synthesis Pathway |
| CS/DS Degradation Pathway | CS/DS Degradation Pathway |
| Cell Adhesion Molecules (CAMs) Pathway | Cell Adhesion Molecules (CAMs) Pathway |
| Chondroitin Sulfate Biosynthesis Pathway | Chondroitin Sulfate Biosynthesis Pathway |
| Chondroitin Sulfate/dermatan Sulfate Metabolism Pathway | Chondroitin Sulfate/dermatan Sulfate Metabolism Pathway |
| Defective B3GAT3 Causes JDSSDHD Pathway | Defective B3GAT3 Causes JDSSDHD Pathway |
| Defective B4GALT1 Causes B4GALT1-CDG (CDG-2d) Pathway | Defective B4GALT1 Causes B4GALT1-CDG (CDG-2d) Pathway |
| Defective B4GALT7 Causes EDS, Progeroid Type Pathway | Defective B4GALT7 Causes EDS, Progeroid Type Pathway |
| Defective CHST14 Causes EDS, Musculocontractural Type Pathway | Defective CHST14 Causes EDS, Musculocontractural Type Pathway |
Diseases associated with VS ELISA Kit
| Nervous System Diseases | publications with VS and Nervous System Diseases |
| Inflammation | publications with VS and Inflammation |
| Fibrosis | publications with VS and Fibrosis |
| Heart Diseases | publications with VS and Heart Diseases |
| Atherosclerosis | publications with VS and Atherosclerosis |
| Breast Neoplasms | publications with VS and Breast Neoplasms |
| Skin Neoplasms | publications with VS and Skin Neoplasms |
| Disease Models, Animal | publications with VS and Disease Models, Animal |
| Lung Neoplasms | publications with VS and Lung Neoplasms |
| Ovarian Neoplasms | publications with VS and Ovarian Neoplasms |
Organs/Tissues associated with VS ELISA Kit
| Vascular | publications with VS and Vascular |
| Muscle | publications with VS and Muscle |
| Connective Tissue | publications with VS and Connective Tissue |
| Blood | publications with VS and Blood |
| Skin | publications with VS and Skin |
| Nerve | publications with VS and Nerve |
| Brain | publications with VS and Brain |
| Bone | publications with VS and Bone |
| Embryonic Tissue | publications with VS and Embryonic Tissue |
| Lung | publications with VS and Lung |